Comparison of Absorption Rate and Bioavailability of Two Brands of Carbamazepine

Journal of Association of Physicians of India

Volumn 47, Issue 7, 1999, Pages 699-702

  Revankar, S N ^a   Desai, N D ^a   Bhatt, A D ^a   Bolar, H V ^a   Sane, S P ^a   Gupta, C ^b   Kamat, D V ^b  

^a Novartis India Limited   (India)

^b SPC Biokinetic Study Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PHARMACOKINETICS; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTICONVULSANTS; BIOLOGICAL AVAILABILITY; CARBAMAZEPINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; HUMANS; MALE; THERAPEUTIC EQUIVALENCY;

EID: 0033156722     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Pynnonen S, Mantyla R, Iisalo E. Unavailability of four different pharmaceutical preparations of carbamazepine. Acta Pharmacol Toxicol 1978; 43 : 306-10.
2. Kuako K, Tammisto P. Comparison of two generically equivalent carbamazepine preparations. Ann Clin Research 1974; 6 : 21-5.
3. Kayali A, Tuglular I, Ertas M. Pharmacokinetics of carbamazepine Part I : A new bioequivalensy parameter based on a relative bioavailability trial. Eur J Drug Metabol Pharmacokinet. 1994; 4 : 319-25.
4. Davidson AG. A multinational study of the quality of carbamazepine tablets. Drug Dev Indust Pharm (USA) 1993; 21 : 2167-86.
5. Bhatia SC, Bhatt AD, Bakshi R, et al. Comparative bioavailability with two brands of carbamazepine - Tegretol® and Mazetol® in healthy volunteers. J Assoc Phys Ind 1988; 36 (10): 611-2.
6. Meyer MC, Straughn AB, Jarvi KJ, Wood GC, et al. The bioequivalence of carbamazepine tablets with a history of clinical failures. Pharm Research 1992; 9 : 1612-6.
7. Koch-Weser J. Bioavailability of drugs. New Eng J Med 1974b; 291 : 503-8.
8. Menge G, Dubois JP, Baner G. Simultaneous determination of carbamazepine, oxcarbazepine and their main metabolites in plasma by liquid chromatography. J Chromatogr 1987; 414 : 477-83.
9. Yamaoka K, Nakagawa T, Uno T. Statistical moments in pharmacokinetics. J Pharmakin Biopharm 1978; 6 : 547-58.
10. Guidance for industry - Immediate release solid oral dosage form, prepared by SUPAC and issued by CDER. Nov. 1995.
11. Williams RL. Bioequivalence and therapeutic equivalence. In: Welling PG, Tse FLS, Dighe SV editors. Pharmaceutical bioequivalence. New York, Marcel Dekker. 1991; 1-16.